0001682338-18-000003.txt : 20180329
0001682338-18-000003.hdr.sgml : 20180329
20180329095239
ACCESSION NUMBER: 0001682338-18-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180329
DATE AS OF CHANGE: 20180329
EFFECTIVENESS DATE: 20180329
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Grid Therapeutics LLC
CENTRAL INDEX KEY: 0001682338
IRS NUMBER: 813371488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-308859
FILM NUMBER: 18720821
BUSINESS ADDRESS:
STREET 1: THE IMPERIAL BUILDING, 215 MORRIS ST
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919987-7190
MAIL ADDRESS:
STREET 1: THE IMPERIAL BUILDING, 215 MORRIS ST
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27701
FORMER COMPANY:
FORMER CONFORMED NAME: Cue Biologics, LLC
DATE OF NAME CHANGE: 20160815
D
1
primary_doc.xml
X0708
D
LIVE
0001682338
Grid Therapeutics LLC
THE IMPERIAL BUILDING, 215 MORRIS ST
SUITE 300
DURHAM
NC
NORTH CAROLINA
27701
919-987-7190
DELAWARE
Cue Biologics, LLC
Limited Liability Company
true
2014
Edward
F.
Patz, Jr.
The Imperial Building
215 Morris St, Suite 300
Durham
NC
NORTH CAROLINA
27701
Executive Officer
Director
Promoter
Scott
Lyman
The Imperial Building
215 Morris St, Suite 300
Durham
NC
NORTH CAROLINA
27701
Executive Officer
Paolo
Paoletti
The Imperial Building
215 Morris St, Suite 300
Durham
NC
NORTH CAROLINA
27701
Director
Kevin
Schulman
The Imperial Building
215 Morris St, Suite 300
Durham
NC
NORTH CAROLINA
27701
Director
Richard
Parker
The Imperial Building
215 Morris St, Suite 300
Durham
NC
NORTH CAROLINA
27701
Director
Thomas
L.
Patz
The Imperial Building
215 Morris St, Suite 300
Durham
NC
NORTH CAROLINA
27701
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2018-03-15
false
true
false
0
5000000
4540451
459549
false
12
0
0
0
Proceeds will be used for working capital, which may include normal compensation to executive officers.
false
Grid Therapeutics LLC
Edward F. Patz, Jr.
Edward F. Patz, Jr.
Chief Executive Officer
2018-03-27